Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. UPLOAD Other SEC-generated Letter
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. 4 Open-market buy Director bought 168 shares at an average $3.44 ($578)
  4. 4 Open-market buy Director bought 340 shares at an average $3.43 ($1,166)
  5. 4 Open-market buy Chairman and CEO bought 340 shares at an average $3.43 ($1,166)
  6. 4 Open-market buy Director bought 1,712 shares at an average $3.43 ($5,872)
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. UPLOAD Other SEC-generated Letter
  10. 4 Open-market buy Director bought 84 shares at an average $4.80 ($404)
  11. 4 Open-market buy Chairman and CEO bought 168 shares at an average $4.80 ($807)
  12. 4 Open-market buy Director bought 168 shares at an average $4.80 ($807)
  13. 4 Open-market buy Director bought 935 shares at an average $4.83 ($4,513)
  14. 4 Open-market buy Director bought 945 shares at an average $5.11 ($4,824)
  15. 4 Open-market buy Director bought 168 shares at an average $5.11 ($858)
  16. 4 Open-market buy Director bought 84 shares at an average $5.11 ($429)
  17. 4 Open-market buy Chairman and CEO bought 168 shares at an average $5.11 ($858)
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 4 Open-market buy Director bought 93 shares at an average $4.48 ($417)
  20. 4 Open-market buy Director bought 186 shares at an average $4.48 ($833)

Page 4 of 52 · 1,039 filings